Trials / Completed
CompletedNCT03690895
Long-term Outcome of AIDS-related Primary Central Nervous System Lymphoma Treated With High Dose Methotrexate and Combined Antiretroviral Therapy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 51 (actual)
- Sponsor
- Fondation Ophtalmologique Adolphe de Rothschild · Network
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims at describing survival rates over time (Kaplan-Meier estimator) in patients suffering from AIDS-related primary central nervous system lymphoma who were diagnosed from 1996 to 2014 and treated with infusions of high-dose methotrexate and combined antiretroviral therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Retrospective survival analysis | Kaplan-Meier model |
Timeline
- Start date
- 2015-03-15
- Primary completion
- 2016-10-01
- Completion
- 2016-10-01
- First posted
- 2018-10-01
- Last updated
- 2018-10-01
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03690895. Inclusion in this directory is not an endorsement.